🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This study aims to investigate the efficacy and safety of PET regimen combi...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2017-03-01
Trial ID
NCT03273452
Treatments Being Tested
To evaluate the benefit of treatment with a physician administered intracan...
Status
Completed
Location
Warrenville EyeCare & LASIK
Start Date
2021-01-04
Trial ID
NCT04658927
Treatments Being Tested
This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Status
Completed
Location
Istituto Giannina Gaslini
Start Date
2006-05-31
Trial ID
NCT00323960
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
In order to treat proliferative IgA Nephropathy(IgAN), The investigators de...
Status
Completed
Location
Research Institute of Nephrology
Start Date
2010-11
Trial ID
NCT01269021
Treatments Being Tested